**Core Concept**
Intravenous immunoglobulin (IVIG) is a therapeutic agent used to modulate the immune system in various autoimmune and inflammatory conditions. IVIG works by neutralizing pathogenic autoantibodies, inhibiting the activation of immune cells, and reducing inflammation.

**Why the Correct Answer is Right**
The correct answer, **C. abe**, includes three conditions where IVIG is indicated: Kawasaki disease (a), myasthenia gravis (e), and Guillain-Barré syndrome (b). In Kawasaki disease, IVIG is used to reduce the risk of coronary artery complications by suppressing the immune response. In myasthenia gravis, IVIG can help manage acute relapses by blocking the action of autoantibodies on acetylcholine receptors. In Guillain-Barré syndrome, IVIG is used to hasten recovery by reducing the production of pathogenic autoantibodies against the nerve sheath.

**Why Each Wrong Option is Incorrect**
**Option A:** Heart block (c) and atrial fibrillation (d) are not indications for IVIG. While IVIG may be used in some autoimmune conditions that can cause cardiac arrhythmias, it is not a treatment for these conditions directly.
**Option B:** Heart block (c) and atrial fibrillation (d) are not indications for IVIG.
**Option D:** Heart block (c) is not an indication for IVIG.

**Clinical Pearl / High-Yield Fact**
IVIG is often used off-label in various conditions, including chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy, and autoimmune hemolytic anemia. When considering IVIG, it's essential to weigh the benefits against potential risks, such as thrombotic events and renal impairment.

**✓ Correct Answer: C. abe. Kawasaki disease, Guillain-Barré syndrome, and myasthenia gravis.**